Decline in Thinking Slowed by Experimental Drug for Alzheimer Disease

WEDNESDAY, May 3, 2023 -- Another experimental drug meant for Alzheimer disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.
Known as donanemab, the medication...